563
Views
42
CrossRef citations to date
0
Altmetric
Reviews

The potential of polymeric film-forming systems as sustained delivery platforms for topical drugs

, &
Pages 349-360 | Received 01 Jul 2015, Accepted 20 Nov 2015, Published online: 18 Dec 2015

References

  • Wester RC, Maibach HI. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab Rev. 1983;14(2):169–205.
  • Surber C, Davis AF. Bioavailability and bioequivalence of dermatological formulations. In: Walter KA, editor. Dermatological and transdermal formulation. Drugs and the pharmaceutical sciences. New York: Marcel Dekker Inc.; 2002. p. 401–498.
  • Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:61–67.
  • Fouéré S, Adjadj L, Pawin H. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol. 2005;19:2–6.
  • Shergill B, Zokaie S, Carr AJ. Non-adherence to topical treatments for actinic keratosis. Patient Prefer Adherence. 2013;8:35–41.
  • Couteau C, Demé A, Cheignon C, et al. Influence of the hydrophilic-lipophilic balance of sunscreen emulsions on their water resistance property. Drug Dev Ind Pharm. 2012;38(11):1405–1407.
  • Roberts MS, Cross SE, Anissimov YG. Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol. 2004;17(1):3–16.
  • Vickers C. Existence of reservoir in the stratum corneum – experimental proof. ArchDermatol. 1963;88:20–23.
  • Vickers CF. Stratum corneum reservoir for drugs. Adv Biol Skin. 1972;12:177–189.
  • Misra A, Raghuvanshi RS, Ganga S, et al. Formulation of a transdermal system for biphasic delivery of testosterone. J Control Release. 1996;39(1):1–7.
  • Schroeder IZ, Franke P, Schaefer UF, et al. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs. J Control Release. 2007;118(2):196–203.
  • Ammar HO, Ghorab M, Mahmoud AA, et al. Rapid pain relief using transdermal film forming polymeric solution of ketorolac. Pharm Dev Technol. 2013;18(5):1005–1016.
  • Ammar H, Ghorab M, El-Nahhas S, et al. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part II: biological evaluation. AAPS PharmSciTech. 2009;10(3):1065–1070.
  • Wang C, Ilani N, Arver S, et al. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men. Clin Endocrinol (Oxf). 2011;75(6):836–843.
  • Wirén K, Frithiof H, Sjöqvist C, et al. Enhancement of bioavailability by lowering of fat content in topical formulations. Br J Dermatol. 2009;160(3):552–556.
  • Tang W, Bhushan B. Adhesion, friction and wear characterization of skin and skin cream using atomic force microscope. Coll Surf B. 2010;76(1):1–15.
  • Timm K, Myant C, Nuguid H, et al. Investigation of friction and perceived skin feel after application of suspensions of various cosmetic powders. Int J Cosmet Sci. 2012;34(5):458–465.
  • Surber C, Smith EW. The mystical effects of dermatological vehicles. Dermatology. 2005;210(2):157–168.
  • Brown M, Evans C, Muddle A, et al. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study. Am J Clin Dermatol. 2013;14(5):413–9.
  • Bhutani T, Koo J, Maibach HI. Efficacy of clobetasol spray: factors beyond patient compliance. J Dermatol Treat. 2012;23(1):11–15.
  • Inc NR DuraPeel. Nuvo Research Inc [Internet]. 2014 4/1/2014. Available from: http://www.nuvoresearch.com/technology/durapeel.
  • Polytherapeutics. Core Technology – PharmaDur(R). Polytherapeutics Inc [Internet]. 2010 4/1/2014. Available from: http://www.polytherapeutics.com/node/3.
  • Kienzler JL, Queille-Roussel C, Mugglestone CJ, et al. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses. Curr Med Res Opin. 2007;23(6):1293–1302.
  • James I, Loria-Kanza Y, Jones TC. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial. J Dermatol Treat. 2007;18(3):163–168.
  • Brown MB, Jones SA, inventors. Topical film-forming monophasic formulations, patent WO 2007/031753 A2. 2007.
  • Jones SA, Reid ML, Brown MB. Determining degree of saturation after application of transiently supersaturated metered dose aerosols for topical delivery of corticosteroids. J Pharm Sci. 2009;98(2):543–554.
  • Reid ML, Brown MB, Jones SA. Manipulation of corticosteroid release from a transiently supersaturated topical metered dose aerosol using a residual miscible co-solvent. Pharm Res. 2008;25(11):2573–2580.
  • Reid ML, Jones SA, Brown MB. Transient drug supersaturation kinetics of beclomethasone dipropionate in rapidly drying films. Int J Pharm. 2009;371(1–2):114–119.
  • Reid ML, Benaouda F, Khengar R, et al. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays. Int J Pharm. 2013;452(1–2):157–165.
  • Lecomte F, Siepmann J, Walther M, et al. Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques. Pharm Res. 2004;21(5):882–890.
  • Siepmann F, Siepmann J, Walther M, et al. Polymer blends for controlled release coatings. J Control Release. 2008;125(1):1–15.
  • Felton LA. Mechanisms of polymeric film formation. Int J Pharm. 2013;457(2):423–427.
  • Katz M, Poulsen BJ. Corticoid, vehicle and skin interaction in percutaneous absorption. J Soc Cosmet Chem. 1972;23(9):565–590.
  • Micali G, Lacarrubba F, Anurekha B The skin barrier. In: Freinkel RK, Woodley DT, et al., editors. The biology of the skin. New York, NY: Taylor & Francis;2001.p. 219–231.
  • Wiedersberg S, Naik A, Leopold CS, et al. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability. Br J Dermatol. 2009;160(3):676–686.
  • Ahlstrom LA, Cross SE, Mills PC. The effects of formulation on the penetration and retention of budesonide in canine skin in vitro. Vet J. 2013;196(3):456–460.
  • Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem. 1960;11(2):85–97.
  • Ishii H, Todo H, Sugibayashi K. Effect of thermodynamic activity on skin permeation and skin concentration of triamcinolone acetonide. Chem Pharm Bull. 2010;58(4):556–561.
  • Schroeder IZ Film forming polymeric solutions as drug delivery systems for the skin [PhD thesis]. Saarbrücken, Germany: Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University; 2007.
  • Huang X, Tanojo H, Lenn J, et al. A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol. 2005;53(1, Supplement):S26–S38.
  • Coldman MF, Poulsen BJ, Higuchi T. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. J Pharm Sci. 1969;58(9):1098–102.
  • Davis AF, Hadgraft J. Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int J Pharm. 1991;76(1–2):1–8.
  • Megrab NA, Williams AC, Barry BW. Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. J Control Release. 1995;36(3):277–294.
  • Chia-Ming C, Flynn GL, Weiner ND, et al. Bioavailability assessment of topical delivery systems: effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations. Int J Pharm. 1989;55(2–3):229–236.
  • Kim JH, Choi HK. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int J Pharm. 2002;236(1–2):81–85.
  • Pellett MA, Castellano S, Hadgraft J, et al. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J Control Release. 1997;46(3):205–214.
  • Moser K, Kriwet K, Froehlich C, et al. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharm Res. 2001;18(7):1006–1011.
  • Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98(8):2549–2572.
  • Poulsen BJ. Diffusion of drugs from topical vehicles: an analysis of vehicle effects. Adv Biol Skin. 1972;12:495–509.
  • Cilurzo F, Minghetti P, Casiraghi A, et al. Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen. Eur J Pharmaceutics Biopharmaceutics. 2005;60(1):61–66.
  • Bajdik J, Regdon G Jr, Marek T, et al. The effect of the solvent on the film-forming parameters of hydroxypropyl-cellulose. Int J Pharm. 2005;301(1–2):192–198.
  • Padula C, Nicoli S, Colombo P, et al. Single-layer transdermal film containing lidocaine: modulation of drug release. Eur J Pharmaceutics Biopharmaceutics. 2007;66(3):422–428.
  • Lin SY, Chen KS, Run-Chu L. Organic esters of plasticizers affecting the water absorption, adhesive property, glass transition temperature and plasticizer permanence of Eudragit acrylic films. J Control Release. 2000;68(3):343–350.
  • Fulzele SV, Satturwar PM, Dorle AK. Polymerized rosin: novel film forming polymer for drug delivery. Int J Pharm. 2002;249(1–2):175–184.
  • Lecomte F, Siepmann J, Walther M, et al. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer. J Control Release. 2004;99(1):1–13.
  • Iervolino M, Cappello B, Raghavan SL, et al. Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int J Pharm. 2001;212(1):131–141.
  • Shelke NB, Sairam M, Halligudi SB, et al. Development of transdermal drug-delivery films with castor-oil-based polyurethanes. J Appl Polym Sci. 2007;103(2):779–788.
  • Williams AC, Barry BW. Penetration enhancers. AdvDrugDeliverRev. 2012;64(Supplement(0)):128–137.
  • Lunter D, Daniels R. In vitro skin permeation and penetration of nonivamide from novel film-forming emulsions. Skin Pharmacol Physiol. 2013;26(3):139–146.
  • Potts R, Guy R. Predicting skin permeability. Pharm Res. 1992;9(5):663–669.
  • Bos JD, Meinardi MMHM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165–169.
  • Cross SE, Magnusson BM, Winckle G, et al. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Investigative Dermatol. 2003;120(5):759–764.
  • Jensen LB, Magnussson E, Gunnarsson L, et al. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int J Pharm. 2010;390(1):53–60.
  • Ito Y, Yoshimura M, Tanaka T, et al. Effect of lipophilicity on the bioavailability of drugs after percutaneous administration by dissolving microneedles. J Pharm Sci. 2012;101(3):1145–1156.
  • Williams AC. Transdermal and topical drug delivery – from theory to clinical practice. London: Pharmaceutical Press; 2003. p. 2003.
  • Brown MB, Martin GP, Jones SA, et al. Dermal and transdermal drug delivery systems: current and future prospects. Drug Delivery. 2006;13(3):175–187.
  • Leichtnam ML, Rolland H, Wüthrich P, et al. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations. J Control Release. 2006;113(1):57–62.
  • Yano T, Nakagawa A, Tsuji M, et al. Skin permeability of various non-steroidal anti-inflammatory drugs in man. LifeSci. 1986;39(12):1043–1050.
  • Wegiel L, Mauer L, Edgar K, et al. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage – impact of different polymers. J Pharm Sci. 2013;102(1):171–184.
  • Pattnaik S, Swain K, Mallick S, et al. Effect of casting solvent on crystallinity of ondansetron in transdermal films. Int J Pharm. 2011;406(1–2):106–110.
  • Leichtnam ML, Rolland H, Wüthrich P, et al. Enhancement of transdermal testosterone delivery by supersaturation. J Pharm Sci. 2006;95(11):2373–2379.
  • Administration USFaD. Inactive ingredient search for approved drug products. FDA Drug Databases [Internet]. 2013 8/23/2013. Available from: http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm.
  • Schroeder IZ, Franke P, Schaefer UF, et al. Development and characterization of film forming polymeric solutions for skin drug delivery. Eur J Pharmaceutics Biopharmaceutics. 2007;65(1):111–121.
  • Wicks ZW, Jones FN, Peppas SP, et al. Organic coatings – science and technology (3rd ed.). New Jersey, NJ: Wiley & Sons, 2006.
  • Pattnaik S, Swain K, Choudhury P, et al. Alfuzosin hydrochloride transdermal films: evaluation of physicochemical, in vitro human cadaver skin permeation and thermodynamic parameters. Int Braz J Urol. 2009;35(6):716–729.
  • Ammar H, Ghorab M, El-Nahhas S, et al. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, Part I: Physicochemical evaluation. AAPS PharmSciTech. 2009;10(1):7–20.
  • Lunter DJ, Daniels R. New film forming emulsions containing Eudragit NE and/or RS 30D for sustained dermal delivery of nonivamide. Eur J Pharmaceutics Biopharmaceutics. 2012;82(2):291–298.
  • Garvie-Cook H, Frederiksen K, Petersson K, et al. Characterization of topical film-forming systems using atomic force microscopy and Raman microspectroscopy. Mol Pharm. 2015;12(3):751–757.
  • Frederiksen K, Guy RH, Petersson K. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin. Eur J Pharmaceutics Biopharmaceutics. 2015;91(0):9–15.
  • Zhang Y, Han JH. Sorption isotherm and plasticization effect of moisture and plasticizers in pea starch film. J Food Sci. 2008;73(7):E313–E24.
  • Bley O, Siepmann J, Bodmeier R. Characterization of moisture-protective polymer coatings using differential scanning calorimetry and dynamic vapor sorption. J Pharm Sci. 2009;98(2):651–664.
  • Robbins CR. Polymers in hair products. Chemical and physical behavior of human hair. Berlin-Heidelberg: Springer; 2012. p. 489–535.
  • Burnette RR, Ongpipattanakul B. Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci. 1987;76(10):765–773.
  • Barel AO, Paye M, Maibach HI. Handbook of cosmetic science and technology. New York, NY: Marcel Dekker Inc; 2001.
  • Marucci M, Hjärtstam J, Ragnarsson G, et al. Coated formulations: new insights into the release mechanism and changes in the film properties with a novel release cell. J Control Release. 2009;136(3):206–212.
  • Misra A, Pal R, Majumdar S, et al. Biphasic testosterone delivery profile observed with two different transdermal formulations. Pharm Res. 1997;14(9):1264–1268.
  • Patel DP, Setty CM, Mistry GN, et al. Development and evaluation of ethyl cellulose-based transdermal films of furosemide for improved in vitro skin permeation. AAPS PharmSciTech. 2009;10(2):437–442.
  • Frohoff-Hülsmann MA, Schmitz A, Lippold BC. Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methylcellulose as coating material for diffusion pellets: I. Drug release rates from coated pellets. Int J Pharm. 1999;177(1):69–82.
  • Hadgraft J. Skin deep. Eur J Pharmaceutics Biopharmaceutics. 2004;58(2):291–299.
  • Raghavan SL, Trividic A, Davis AF, et al. Crystallization of hydrocortisone acetate: Influence of polymers. Int J Pharm. 2001;212(2):213–221.
  • Jain P, Banga AK. Inhibition of crystallization in drug-in-adhesive-type transdermal patches. Int J Pharm. 2010;394(1–2):68–74.
  • •Garvie-Cook H, Frederiksen K, Petersson K, et al. Biophysical elucidation of the mechanism of enhanced drug release and topical delivery from polymeric film-forming systems. J Control Release. 2015;212(0):103–12.
  • Rao PR, Diwan PV. Permeability studies of cellulose acetate free films for transdermal use: influence of plasticizers. Pharm Acta Helv. 1997;72(1):47–51.
  • Rowe RC. Materials used in the film coating of oral dosage forms. In: Florence AT, editor. Materials used in pharmaceutical formulation. Oxford: Blackwell Scientific Publications; 1984. p. 1–36.
  • Sears JK, Darby JR. The technology of plasticizers. New York, NY: John Wily & Sons; 1982. p. 1982.
  • Development OfEC-oa. No 28 - Guidance document for the conduct of skin absorption studies. Paris: OECD Publishing; 2004 3/5/2004.
  • Shao Z, Morales L, Diaz S, et al. Drug release from kollicoat SR 30D-coated nonpareil beads: evaluation of coating level, plasticizer type, and curing condition. AAPS PharmSciTech. 2002;3(2):87–96.
  • Luppi B, Bigucci F, Baldini M, et al. Hydroxypropylmethylcellulose films for prolonged delivery of the antipsychotic drug chlorpromazine. J Pharm Pharmacol. 2010;62(3):305–309.
  • Mohammed D, Hirata K, Hadgraft J, et al. Influence of skin penetration enhancers on skin barrier function and skin protease activity. Eur J Pharm Sci. 2014;51(0):118–122.
  • Ting WW, Vest CD, Sontheimer RD. Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Int J Dermatol. 2004;43(7):538–547.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.